What is Forward Clinical Trials?
Forward Clinical Trials is a specialized clinical research organization (CRO) focusing on Dermatology and Family Medicine. The company is equipped to conduct Phase II through IV studies, leveraging a team of Principal Investigators, Sub-Investigators, and research staff trained in Good Clinical Practice (GCP) and the company's Standard Operating Procedures (SOPs). FCT is recognized for its ability to consistently achieve high patient enrollment numbers, working with recruitment companies and maintaining a diverse database of potential research subjects. Their operational efficiency extends to rapid contract and regulatory document turnaround, facilitating timely study initiation. Furthermore, FCT collaborates with local Radiology Centers to meet specific imaging requirements for protocols, ensuring comprehensive study support.
How much funding has Forward Clinical Trials raised?
Forward Clinical Trials has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Forward Clinical Trials
PPP
Public-Private Partnership
What's next for Forward Clinical Trials?
The recent large-scale late-stage funding, characterized as a major strategic investment, positions Forward Clinical Trials for accelerated growth and enhanced operational capacity. This capital infusion is expected to fuel expansion into new therapeutic areas or deepen existing specializations within Dermatology and Family Medicine. The company's focus on quality data, patient safety, and efficient trial execution, combined with its strong recruitment capabilities and established relationships with pharmaceutical sponsors, suggests a strategic trajectory aimed at solidifying its role as a leading CRO. Future developments may include expanding research infrastructure, forging new strategic partnerships, and increasing the scope of clinical trials undertaken.
See full Forward Clinical Trials company page
